Breast cancer statistics, 2019
By C. DeSantis, Jiemin Ma, M. Gaudet, L. Newman, K. Miller, Ann Goding Sauer, A. Jemal, R. Siegel. Ca, 2019
2,622 citations recorded by the source corpus.
This article is the American Cancer Society’s biennial update on female breast cancer statistics in the United States, including data on incidence, mortality, survival, and screening. Over the most recent 5‐year period (2012‐2016), the breast cancer incidence rate increased slightly by 0.3% per year, largely because of rising rates of local stage and hormone receptor‐positive disease. In contrast, the breast cancer death rate continues to decline, dropping 40% from 1989 to 2017 and translating to 375,900 breast cancer deaths averted. Notably, the pace of the decline has slowed from an annual decrease of 1.9% during 1998 through 2011 to 1.3% during 2011 through 2017, largely driven by the trend in white women. Consequently, the black–white disparity in breast cancer mortality has remained stable since 2011 after widening over the past 3 decades. Nevertheless, the death rate remains 40% higher in blacks (28.4 vs 20.3 deaths per 100,000) despite a lower incidence rate (126.7 vs 130.8); this disparity is magnified among black women aged <50 years, who have a death rate double that of whites. In the most recent 5‐year period (2013‐2017), the death rate declined in Hispanics (2.1% per year), blacks (1.5%), whites (1.0%), and Asians/Pacific Islanders (0.8%) but was stable in American Indians/Alaska Natives. However, by state, breast cancer mortality rates are no longer declining in Nebraska overall; in Colorado and Wisconsin in black women; and in Nebraska, Texas, and Virginia in white women. Breast cancer was the leading cause of cancer death in women (surpassing lung cancer) in four Southern and two Midwestern states among blacks and in Utah among whites during 2016‐2017. Declines in breast cancer mortality could be accelerated by expanding access to high‐quality prevention, early detection, and treatment services to all women.
Subfields: Cancer Research, Oncology
View Paper: https://www.semanticscholar.org/paper/b444ffb1b0e38ec41a73872856c2ef55524fbeeb
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
Citations in the corpus
- Overcoming Endocrine Resistance in Breast Cancer (2020, neutral): “Of these, nearly 80% are estrogen receptor-positive (ER+) (DeSantis et al., 2019).”
- Annual report to the nation on the status of cancer, part 1: National cancer statistics (2022, neutral): “5% per year, which coincides with the deceleration of declining death rates, potentially slowing the progress against breast cancer death achieved since the early 1990s.(55,56) The increase in breast cancer incidence may reflect continuing decreases in parity rates(57,58) and advancing age at first ”
- Current and future burden of breast cancer: Global statistics for 2020 and 2040 (2022, background): “Rising incidence rates have been reported in several high-income countries in North America, Europe and Oceania since 2007 for pre- and postmenopausal breast cancer [2,20].”
- Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020 (2021, background): “Previous studies have only focused on the comparison of breast cancer burden betweenworld regions or the description in one country [1, 15, 18, 19].”